TCTR20211012001已完成不适用
The study of the treatment efficacy in prostate cancer with low dose abiraterone
/A0 个研究点目标入组 21 人开始时间: 2021年10月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- Male
入选标准
- •1. Metastatic prostate cancer patients who are not previously received chemotherapy.
- •2. Patients agree to consent for the study.
- •3. ECOG performance status 0-2
排除标准
- •1. Patient who has prior treatment with abiraterone or enzalutamide.
- •2. Patient who has received treatment with drug or other procedure such as
- •radiation therapy and radionuclear Radium 223 method.
研究者
相似试验
尚未招募
1 期
A real world study on the treatment of prostate cancer by integrated Chinese and Western medicineProstate cancerITMCTR2200006847Guangdong Provincial Hospital of Chinese Medicine
招募中
不适用
Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)Prostate cancer patients with bone metastasisJPRN-UMIN000011648Osaka University160
招募中
不适用
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
已完成
不适用
Outcome study of hormonal therapy for prostate cancer in JapaProstate cancerJPRN-C000000252J-CaP study group24,000
尚未招募
不适用
Evaluation of safety and efficacy in prostate cancer patients treated with focal low-dose-rate brachytherapyProstate cancerJPRN-UMIN000030509Kitasato University School of Medicine, Department of Urology20